Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening? Christopher L. Amling OriginalPaper Pages: 337 - 345
Should finasteride be used to prevent prostate cancer? Neil FleshnerGirish Kulkarni OriginalPaper Pages: 346 - 354
Active surveillance versus radical treatment for favorable-risk localized prostate cancer Laurence Klotz OriginalPaper Pages: 355 - 362
Testosterone therapy for men at risk for or with history of prostate cancer Abraham Morgentaler OriginalPaper Pages: 363 - 369
Cytotoxic chemotherapy for prostate cancer: Who and when? Rebecca A. MossDaniel P. Petrylak OriginalPaper Pages: 370 - 377
Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer Vicki L. KeedyJordan Berlin OriginalPaper Pages: 381 - 388
Metastatic colorectal cancer: Therapeutic options Smitha PatiyilSteven R. Alberts OriginalPaper Pages: 389 - 398
Liver-directed therapies for patients with primary liver cancer and hepatic metastases Cletus A. ArcieroElin R. Sigurdson OriginalPaper Pages: 399 - 409
Cancer of the gastroesophageal junction: Current therapy options David H. Ilson OriginalPaper Pages: 410 - 423
